Art

J-GLOBAL ID：201102242109283154   Reference number：11A1378948

Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation - A Multicenter Study of Its Status and Influential Factors -

非弁膜症心房細動日本人患者におけるワーファリン療法中の治療域内時間 現状と影響因子の多施設試験

Author (9)： OKUMURA Ken (Dep. of Cardiology, Hirosaki Univ. Hospital) ,  KOMATSU Takashi (Dep. of Cardiology, Iwate Medical Univ. Hospital) ,  YAMASHITA Takeshi (Dep. of Cardiovascular Medicine, The Cardiovascular Inst.) ,  OKUYAMA Yuji (Dep. of Cardiology, Osaka General Medical Center) ,  HARADA Masahiko (Dep. of Cardiology, Ube Ind. Central Hospital) ,  KONTA Yoshiyuki (Dep. of Internal Medicine, Reimeikyo Rehabilitation Hospital) ,  HATAYAMA Toru (Hatayama Clinic) ,  HORIUCHI Daisuke (Dep. of Cardiology, Hirosaki Univ. Hospital) ,  TSUSHIMA Eiki (Dep. of Physical Therapy, Hirosaki Univ. School of Health Sci.)
Material： Circulation Journal  (Circ J)
Volume： 75  Issue： 9  Page： 2087-2094 (J-STAGE)  Publication year： 2011 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *auricular fibrillation ,...
Semi thesaurus term： 治療域内時間 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1378948&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (1)： Warfarin

Reference (23)：

• 1. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501.
• 2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation 2006; 114: e257-e354.
• 3. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1420.
• 4. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): Digest version. Circ J 2010; 74: 2479-2500.
• 5. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.

Terms in the title (9)： 非弁膜症心房細動 ,  日本人 ,  患者 ,  ワーファリン ,  療法 ,  治療 ,  現状 ,  影響因子 ,  多施設試験